The GAVI Alliance or the Global Alliance for Vaccines and Immunisation, is an important international partnership between some of the main public and private actors operating in the field of vaccination, according to WHO estimates, from its creation in 2000, at the end of 2007, has extended access to vaccinations to 176 million children allowing così to prevent more than 2.9 million deaths.
The Alliance has now approved the new strategy that identifies immunizations to support in priority in order to fight some of the diseases more deadly in developing countries. The support to be given in the future regarding vaccination against cervical cancer, cholera, typhoid, meningitis A, rabies, japanese encephalitis and rubella.
The GAVI alliance provides già support to developing nations for the deployment of vaccines against hepatitis B, infection with Haemophilus B, yellow fever, diseases from, Rotavirus and Pneumococcal, and in the coming months, valueà the remaining immunoprophylaxis priority, taking into account the demand of countries such as the availabilityà of resources, and vaccines.
The Board of directors will gatherà in the second halfà of this year to take decisions on the financial commitment of the Covenant and on the implementation of the strategy. This is based on a list of priority diseases identified by the WHO and the new vaccines which will be available for the developing countries in the next decade, including those provided even one against malaria.
the members of The Board have found that, for the implementation of the new strategy to be necessaryà increased donor support, but they have also said that the success of the recent actions would have made of the activitiesà of vaccination an attractive investment for the funds for the development. The strategy is illustrated on the site www.gavialliance.org.
Page published on July 17, 2008